Madam Speaker, it is quite the contrary. Canada is in a very privileged position with a diversified portfolio of vaccine candidates. We look forward to the regulatory approval of all of those. In fact, of the first three that have received encouraging news, Canada has arrangements with all three of those vaccine candidates.
Canada compares very favourably. For example, with the Moderna vaccine, we were among the first in the world, in front the U.K. Canada is in a very good position. When vaccines are ready, Canada will be ready.